date:Sep 21, 2012
DuPont Nutrition Health has entered into an agreement to acquire exclusive rights to AvidBiotics antibacterial protein technology in the broad realm of food and food protection.
AvidBiotics will retain all rights to applications of its technology in the fields of animal health, human therapeutics, human prophylactics and human diagnostics.
The agreement, which includes a DuPont Ventures equity investment, will focus on developing and commercializing avidbiotics' purocin protein antibacterial